1[1]Bierhaus A, Hofmann MA, Ziegler R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept[J]. Cardiovasc Res, 1998, 37(3):586-600.
2[5]Wang J, Walsh K. Resistance to apoptosis conferred by cdk inhibitors during myocyte differentiation[J]. Science, 1996, 273 (5273): 359-61.
3[6]Wells-knecht K J, Brinkmann E. New biomarkers of Maillard reaction damage to protein[J]. Nephrol Dial Transplant, 1996, 1 l(Suppl 5):41-7.
4[7]Min C, Kang E, Yu SH, et al. Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells[J]. Diabetes Res Clin Pract, 1999,46(3): 197-202.
5[8]Yamagishi S, Inagaki Y, Okamoto T, et al. Advanced glycation end products-induced apoptosis of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human cultured messangial cells[J]. J Biol Chem, 2002, 277(23): 20309-15.
6[9]Saraste A, Pulkki K, Kallajoki M, et al. Apoptosis in hunan acute myocardial infarction[ J ]. Circulation, 1997, 95(2): 320-3.
7[10]Olivetti C, Abbi R, Quaini F, et al. Apoptosis in the failing hman heart[J]. N Engl J Med, 1997, 336(16): 1131-41.
8[11]Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes[J]. Cir Res, 1994, 75(3): 426-33.
9[12]Turner NA, Xia F, Azhar G, et al. Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells[J]. J Mol Cell Cardiol,1998, 30(9): 1789-801.
